Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of 41.73% is 39% above its 5-year average of 29.99%, near the high end of its 5-year range (0.00%–57.34%).
21.96% above its 12-month average of 34.22%.
Reported quarterly gross margin; no daily interpolation. Q4 FY2025 (2025-12-31): 43.88%.
GROSS MARGIN
41.73%
GROSS MARGIN AVG TTM
34.22%
GROSS MARGIN AVG 3Y
23.66%
GROSS MARGIN AVG 5Y
29.99%
GROSS MARGIN AVG 10Y
N/A
GROSS MARGIN AVG 15Y
N/A
GROSS MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+21.96%
CURRENT VS 3Y AVG
+76.36%
CURRENT VS 5Y AVG
+39.12%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
41.38%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
+0.85%
vs the sector median at left
EUDA Health Holdings Limited
Market Cap
$35.69M
Gross Margin
41.73%
TTM Avg
34.22%
3Y Avg
23.66%
5Y Avg
29.99%
Market Cap
$36.28M
Gross Margin
39.56%
TTM Avg
49.73%
3Y Avg
-33.76%
5Y Avg
-21.28%
Market Cap
$36.51M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
22.09%
Market Cap
$35.50M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$34.50M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
10.20%
Market Cap
$37.81M
Gross Margin
0.00%
TTM Avg
-93.03%
3Y Avg
-21.51%
5Y Avg
10.85%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| EUDA Health Holdings Limited (EUDA) | $35.69M | 41.73% | 34.22% | 23.66% | 29.99% |
| QT Imaging Holdings, Inc. (QTI)vs › | $36.28M | 39.56% | 49.73% | -33.76% | -21.28% |
| Elicio Therapeutics, Inc. (ELTX)vs › | $36.51M | 0.00% | 0.00% | 0.00% | 22.09% |
| DocGo Inc. (DCGO)vs › | $35.57M | 30.12% | 32.64% | 32.93% | 33.24% |
| Edesa Biotech, Inc. (EDSA)vs › | $36.70M | 0.00% | 0.00% | 0.00% | 15.78% |
| BriaCell Therapeutics Corp. (BCTX)vs › | $35.50M | 0.00% | 0.00% | 0.00% | 0.00% |
| Grace Therapeutics, Inc. (GRCE)vs › | $34.50M | 0.00% | 0.00% | 0.00% | 10.20% |
| Incannex Healthcare Limited (IXHL)vs › | $37.81M | 0.00% | -93.03% | -21.51% | 10.85% |
| Nephros, Inc. (NEPH)vs › | $37.89M | 60.31% | 61.36% | 57.30% | 56.95% |
| Elutia Inc (ELUT)vs › | $34.48M | 57.82% | 48.80% | 47.77% | 46.56% |
Gross Margin
41.7%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2025-12-31 | 43.88% |
| 2025-09-30 | 57.34% |
| 2025-06-30 | 27.32% |
| 2025-03-31 | 27.32% |
| 2024-12-31 | 15.22% |
| 2024-09-30 | 15.22% |
| 2024-06-30 | 23.17% |
| 2024-03-31 | 23.17% |
| 2023-12-31 | 20.93% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 26.92% |
| 2023-03-31 | 23.76% |
| 2022-12-31 | 33.59% |
| 2022-10-31 | 26.16% |
| 2022-06-30 | 27.21% |
| 2022-03-31 | 47.67% |
| 2021-12-31 | 41.33% |
| 2021-09-30 | 36.94% |
| 2021-06-30 | 39.81% |
| 2021-03-31 | 42.95% |
